J.B. Chemicals & Pharmaceuticals has informed that the Compensation Committee of the Board of Directors of the Company has, on November 29, 2023 allotted 10,210 fully paid-up equity shares of Re 1 each of the Company, to certain employees on exercise of stock options granted to them pursuant to JBCPL Employee Stock Option Scheme, 2021. An amount of Rs 61,26,000 has been realised on exercise of 10,210 stock options. Consequently, the issued, subscribed and paid-up capital (adjusted for split in face value) has increased from 15,50,33,950 equity shares of Re 1 each to 15,50,44,160 equity shares of Re 1 each.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1453.25 |
Dr. Reddys Lab | 5792.95 |
Cipla | 1459.85 |
Zydus Lifesciences | 1032.25 |
Lupin | 1583.95 |
View more.. |